10/26/09, (NYSE:LLY), $33.91, "BUY" LILLY ELI CO (LLY) Stock on Monday, October 26, 2009

Login    About Us    Our Blog    Our Twitter    Contact Us     10/26/09, (NYSE:LLY), $33.91, "BUY" LILLY ELI CO (LLY) Stock  LLY opened at $34.05 and it is $-0.05, (-0.15%). Today's trading range is $33.73 - 34.40. 1y target price is $36.69.  DOW     -1.05%    -104.22    9867.96           ENGLAND     -0.97%    -50.83    5191.74           JAPAN     Updating    Updating    10362.62  NASDAQ     -0.59%    -12.62    2141.85           GERMANY     -1.71%    -98.09    5642.16           CHINA     Updating    Updating    3109.566  S&P 500     -1.17%    -12.65    1066.95           FRANCE     -1.68%    -63.79    3744.45           INDIA     Updating    Updating    16740.50  CANADA     -1.29%    -147.25    11234.88           ITALY     -1.09%    -174.00    15743.00           RUSSIA     +1.01%    +14.76    1476.06  MEXICO     -1.10%    -337.6    30280.080           SWISS     -1.17%    -74.71    6303.35           TAIWAN     Updating    Updating    7668.40

Stocks Funds SYMBOL:    YouTube Our Blog 10/17/09 StockRing Urgent Advice: Sell stocks on 10/19/09 - expect pull back this week !!!    Option Exp: SAMPLE ! Option Exp: Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on  TODAY :  Buy   77% or 23   Hold   16% or 5   Sell   7% or 2 stocks 2. Best Brands - 200 stocks on  TODAY :  Buy   66% or 132   Hold   13% or 26   Sell   21% or 41 stocks 3. Hot News - 200 stocks on 10/6/2009:  Buy   71% or 141   Hold   -2% or -4   Sell   31% or 62 stocks 4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75   Hold   17% or 17   Sell   8% or 8 stocks 8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78   Hold   33% or 45   Sell   10% or 13 stocks 10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks     17. World Markets - 72 Indexes on 10/23/2009:  Buy   86% or 60   Hold   4% or 3   Sell   10% or 7 indexes                                              TOTAL RATINGS:   Buy   79% or 2395   Hold   2% or 998   Sell   19% or 535 stocks Video: 10-10-09 - Stock Market Report for S&P 500 stocks 10/26/2009  Monday, October 26, 2009 (Irvine, California) Today StockRing.com Recommendation is to "BUY"for LILLY ELI CO (NYSE:LLY) Stock. LLY stock opening price was $34.05 per share. Current price of NYSE:LLY Stock is $33.91 per share and it is $-0.05, (-0.15%) today and it was trading in the daily range of $33.73 - 34.40 per share. Current Bid Price for (NYSE:LLY) stock is $34.00 and the Ask Price is $34.10. In the last 52 weeks LLY stock was trading in the range of $27.21 - 40.78. 50-Day Moving Average for (NYSE:LLY) stock is $33.274 and 200-Day Moving Average is $33.7376. On average analysts predict that One Year Target Estimated price for (NYSE:LLY) stock is $36.69. LILLY ELI CO (NYSE:LLY) Market capitalization is $38.963B. (NYSE:LLY) stock average daily volume is 6,425,610 shares per day. However, on last trading session of 4:00pm, 2009 LLY stock traded 8,003,737 shares. Also The Short Ratio for (NYSE:LLY) stock is 4.70. On previous trading session LLY Stock closed at $33.96 per share. Last year LILLY ELI CO (NYSE:LLY) before taxes (EBITDA) (ttm) earned $7.793B on total revenue of $21.112B. Earnings Per Share - EPS (ttm) for LLY stock is -0.197. Thus, (NYSE:LLY) Stock Price/Sales (ttm) ratio is 1.85 and Price/Book (mrq) ratio is 4.56. (NYSE:LLY) Stock pays a dividend of $1.94 per share which is a yield of 5.71%. So at this time (NYSE:LLY) Stock maintains Trailing Annual Dividend Rate at 1.94 . StockRing Recommendations for LILLY ELI CO (NYSE:LLY) Stock are updated daily here http://www.StockRing.com/sr/StockDetail.asp?StockName=LLY If you would like to receive Buy-Sell-Hold ratings for over 50,000 stocks, mutual funds, and ETFs go to StockRing web site: http://www.StockRing.com. LLY Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 10/26/2009 1 Year Stock market price chart for LILLY ELI CO (NYSE:LLY) Stock on Monday, October 26, 2009    1 Year Dow Jones Chart 1 Year S&P 500 Chart 1 Year Nasdaq Chart 1 Year Canada Chart 10/26/2009 5 days Stock market price chart for LILLY ELI CO (NYSE:LLY) Stock on Monday, October 26, 2009    5 Days Dow Jones Chart 5 Days S&P 500 Chart 5 Days Nasdaq Chart 5 Days Canada Chart LLY Stock Charts:   1d   5d   3m   6m   1y   2y   5y   Max   News    Options!   More Info 10/26/2009 Stock market price quote data for LILLY ELI CO (NYSE:LLY) Stock on Monday, October 26, 2009 Last Trade: 33.91 Trade Time: 4:00pm Change: -0.05, (-0.15%) Prev Close: 33.96 Open: 34.05 Bid: 34.00 Ask: 34.10 1y Target Est: $36.69 50-Day Moving Average: 33.274 200-Day Moving Average: 33.7376 Short Ratio: 4.70 Trailing Annual Dividend Rate: 1.94 Day's Range: 33.73 - 34.40 52wk Range: 27.21 - 40.78 Volume: 8,003,737 Avg Vol: 6,425,610 Market Cap: 38.963B P/E (ttm): N/A EPS (ttm): -0.197 Div & Yield: 1.94 (5.71%) Revenue (ttm): 21.112B Earnings before Tax (EBITDA) (ttm): 7.793B Price/Sales (ttm): 1.85 Price/Book (mrq): 4.56 Receive FRESH Daily Updates for 17 StockRing Reports for $30/month !!! 1. Dow Jones Index - 30 Stocks on  TODAY :  Buy   77% or 23   Hold   16% or 5   Sell   7% or 2 stocks 2. Best Brands - 200 stocks on  TODAY :  Buy   66% or 132   Hold   13% or 26   Sell   21% or 41 stocks 3. Hot News - 200 stocks on 10/6/2009:  Buy   71% or 141   Hold   -2% or -4   Sell   31% or 62 stocks 4. S&P 500 Index - 500 Stocks on 7/21/2009:   Buy   68% or 341   Hold   21% or 106   Sell   11% or 53 stocks 5. S&P 400 Mid Cap - 400 Stocks on 7/21/2009:  Buy   73% or 292   Hold   15% or 61   Sell   12% or 47 stocks 6. S&P 600 Small Cap - 600 Stocks on 4/18/2009:  Buy   66% or 395   Hold   26% or 156   Sell   8% or 49 stocks 7. Nasdaq 100 Index - 100 Stocks on 7/21/2009:  Buy   75% or 75   Hold   17% or 17   Sell   8% or 8 stocks 8. Nasdaq Telecom - 164 Stocks on 7/24/2009:  Buy   49% or 81   Hold   35% or 56   Sell   16% or 27 stocks 9. Nasdaq Biotech - 136 Stocks on 7/24/2009:  Buy   57% or 78   Hold   33% or 45   Sell   10% or 13 stocks 10. Nasdaq Computer - 440 Stocks on 7/22/2009:  Buy   60% or 263   Hold   26% or 115   Sell   14% or 62 stocks 11. Nasdaq Finance - 180 Stocks on 7/24/2009:  Buy   61% or 109   Hold   6% or 12   Sell   33% or 59 stocks 12. NYSE International - 100 Stocks on 7/21/2009:  Buy   58% or 58   Hold   34% or 34   Sell   8% or 8 stocks 13. Legg Mason Mutual - 346 Funds on 10/6/2009:  Buy   38% or 133   Hold   51% or 176   Sell   11% or 37 funds 14. T. Row Price Mutual - 161 Funds on 10/6/2009:  Buy   52% or 84   Hold   46% or 73   Sell   2% or 4 funds 15. London FTSE 100 - 94 Stocks on 4/1/2009:  Buy   20% or 19   Hold   50% or 47   Sell   30% or 28 stocks 16. Canada Toronto - 209 Stocks on 4/18/2009:  Buy   53% or 111   Hold   34% or 70   Sell   13% or 28 stocks     17. World Markets - 72 Indexes on 10/23/2009:  Buy   86% or 60   Hold   4% or 3   Sell   10% or 7 indexes                                              TOTAL RATINGS:   Buy   79% or 2395   Hold   2% or 998   Sell   19% or 535 stocks 10/26/2009 Latest stock market news data for LILLY ELI CO (NYSE:LLY) Stock on Monday, October 26, 2009 Backlash fear over 'diabetes disaster' The Australian - 8 hours ago DRUG giant Eli Lilly is facing a potential backlash over its funding of a report warning that Australia faces a diabetes "disaster", with experts concerned it could be seen as a marketing push to ... Three European Analyses Showed Efient is Cost-Effective Compared with Clopidogrel in Patients with Acute Coronary Syndrome Undergoing PCI PresseEcho.de - 14 hours ago Paris (ots/PRNewswire) - Results from three separate European health economic analyses of the TRITON-TIMI 38 study showed that treatment with Efient(R) (prasugrel) compared with clopidogrel ... SC settles with Eli Lilly over Zyprexa marketing Winston-Salem Journal - 17 hours ago AP COLUMBIA, SC - South Carolina's attorney general said Friday that the state has reached a $45 million settlement with drug-maker Eli Lilly & Co. over the company's marketing of an anti ... South Carolina Attorney General Reaches $45M Deal with Lilly - Pharmaceutical Processing SC, Lilly reach $45M Zyprexa settlement; Lower costs help Ranbaxy beat profit estimates; - FiercePharma The Indianapolis Star Daniel Lee Column: Indiana Working to Create Its Own Identity With Investors istockAnalyst.com - Oct 25, 2009 (Source: The Indianapolis Star) By Daniel Lee, The Indianapolis Star Oct. 25--Indiana Secretary of Commerce Mitch Roob and some of his staffers at the Indiana Economic Development Corp. have ... A sitdown with Eli Lilly & Co.'s CEO Charleston Post Courier - Oct 25, 2009 AP INDIANAPOLIS — There are some life experiences few will ever have. And as the oldest of nine children and CEO of a Fortune 500 company, John Lechleiter has a couple under his belt. As Eli Lilly ... GE, Lilly deepen cancer drug effort - Fort Wayne Journal Gazette Eli Lilly CEO banking on new drug pipeline - Dubuque Telegraph Herald FierceBiotech IT - Inside INdiana Business - Manufacturing & Technology eJournal Economic Hardship Boosting Cialis Sales The Business Insider - Oct 23, 2009 Despite weakness in the overall economy, Eli Lilly's Cialis sales continue to grow in terms of volume. They've also been able to continue hiking prices in the latest quarter. The surprising ... APNewsBreak: SC AG reaches $45M deal with Lilly Seattle Post Intelligencer - Oct 23, 2009 By MEG KINNARD AP WRITER COLUMBIA, SC -- South Carolina's attorney general said Friday the state has reached a $45 million settlement with drug maker Eli Lilly & Co. over the company's marketing ... Lilly to Pay South Carolina $45 Million Over Zyprexa - Bloomberg The Dartmouth Psych Kingpin Who's Not on Lilly's List - GoozNew Augusta Chronicle - Journal and Courier - WIS Lilly Meets Energy-Efficiency Goals Ahead of Schedule Environmental Leader - Oct 23, 2009 Eli Lilly, a global pharmaceutical company, has reached its energy goal two years early, improving its energy intensity (energy used per dollar of sales) by more than 35 percent and cutting its ... Lilly CEO Lechleiter touts pipeline FierceBiotech - Oct 23, 2009 Over the next several years, Eli Lilly will be facing generic competition for the antipsychotic Zyprexa, antidepressant Cymbalta and other blockbuster drugs that account for a good portion of the ... Big Pharma results not exciting Investor's Business Daily - Oct 23, 2009 Merck's (MRK) profit beat views; Novartis (NVS) and Bristol-Myers (BMY) were largely in line. Cost cuts helped and sales rose modestly, but the drug makers face the expiration of patents on many ... Lilly's stock meanders, but remains a Buy BloggingStocks (blog) (NYSE: LLY) stock has unexpectedly meandered since the June 8, 2009 Buy recommendation at a price of $34.10, but the aforementioned probably represents ... and more » MiamiHerald.com Lilly posts strong profits, but stock falls Indianapolis Star Eli Lilly and Co. posted strong third-quarter profits, beating analysts' expectations, but the company's stock fell nearly ... Ely Lilly shows classic horizontal rangeoptionMONSTER Research (registration) Eli Lilly CEO banking on new drug pipelineThe Associated Press Eli Lilly Q3 Profit Rises on Higher Revenue; Outlook Boosted (LLY)Dividend.com (blog) Bloomberg -Reuters UK -Medill Reports: Chicago all 585 news articles » BEFORE THE BELL:US Stock Futures Down But Off Lows Wall Street Journal (LLY) returned to the black in the third quarter, after last year's results were hurt by legal settlements for its star drug, the antipsychotic Zyprexa, ... and more » Stock Market Update Briefing.com (YHOO), US Bancorp (USB), and Eli Lilly (LLY). Though broader market stock futures are trailing fair value, the strong individual results have lifted YHOO ... and more » Beat Earnings, Stock Down, Rinse and Repeat Motley Fool For the second quarter in a row, Eli Lilly (NYSE: LLY) beat expectations, it raised guidance, and its stock fell for the day. ... Lightning Round: Gilead Sciences, ADC Telecom, Bank of America and More CNBC () ]: GSK has had a good run, Cramer said, so he can't recommend the stock at this level. He likes Eli Lilly [LLY Loading... () ] and its dividend yield ... 'Mad Money Lightning Round': Gilead's GreatTheStreet.com Cramer's Lightning Round - Stop Worrying About Gilead (10/22/09)Seeking Alpha (blog) all 20 news articles » Stock Market Update Briefing.com (YHOO), and Eli Lilly (LLY). That's not to say the latest stream of reports has been flawless, though. Boeing (BA) fell short of earnings expectations and ... and more » CBC.ca Boeing, Morgan Stanley, Wells Fargo in focus MarketWatch (NYSE:LLY) said it swung to a third-quarter profit, topping forecasts, and lifted its full-year forecast. The drugmaker posted net income of $941.8 million, ... Late Selling Effort Leaves Stocks to Settle with LossBriefing.com all 1,706 news articles » US Stock Futures Point To Lower Open, Wells Fargo (NYSE: WFC) Eyed istockAnalyst.com (press release) (NYSE: LLY) said that it swung to a third quarter profit of $941.8 million, or 86 cents per share, compared to a loss of $465.6 million, or 43 cents per ... and more » Amylin 3Q Loss Narrows Substantially On Cost Cuts, Tops Views Wall Street Journal (LLY), has been reducing costs as it combines some Byetta operations with Eli Lilly. Last month, Amylin and Biocon Ltd. (532523. ... and more » 10/26/2009 News from StockRing Blog about LILLY ELI CO (NYSE:LLY) Stock on Monday, October 26, 2009    Abele John   Abrams George    Abrams Jonathan   Ackermann Josef   ACUSHNET   A.I.G.   AIG   Albright Madeleine   AMAZON.COM   AMERITRADE   Andelman David   Andreessen Marc   Angwin Julia   Anthony Jim   APAX PARTNERS   ARCH VENTURE PARTNERS   ARONSSON GROUP   Ashworth Paul   AT&T   AVON BOOKS   Bair Sheila   BANK OF AMERICA   BARCLAYS   Barton Rich   Bassett Angela   BEAR STEARNS   Begich Mark   Bell Bryon   Bennett Tony   Berke Barry   Bernanke Ben   BET   BETSEY JOHNSON   Biaggi Mario   Bierut Michael   Biondi Frank   Blankfein Lloyd   Blinder Alan   Bock Jeff   BOEING   Boncompagni Tatiana   Bond Adam   Bond Victoria   Born Brooksley   BOSTON SCIENTIFIC   BP   Brazinski Daniel   Breslin Jimmy   Brody Kenneth   Brown Greg   Burkle Ron   Burow Kristina   Burrough Bryan   Bush George W.   Callan Erin   CALLAWAY GOLF   CARLYLE GROUP    CASCADE INVESTMENT   Cassano Joseph   Dauman Philippe   De Niro Robert   Dickerson Paul   Dillon Harrison   DISNEY   Dodd Christopher   Donaldson William   Douglas Michael   Draghi Mario   DREAMWORKS SKG   DUTTON   Dykstra Lenny   Eisner Michael   ELECTRONIC ARTS   Emanuel Rahm   ENRON   ESL INVESTMENTS   Evans Robert   Falcone Philip   FANNIE MAE   FEDERATED DEPARTMENT   STORES   FINANCO   Flavin Jennifer   Fleckenstein Bill   Foreman George   Frank Barney   Frears Stephen   FREDDIE MAC   Freston Tom   Friedman Stephen   Fuld Dick   Furman Roy   Garavani Valentino   Gates Bill   Geffen David   Geithner Tim   GENERAL MOTORS   Gensler Gary   Gerdeman Fred   Gibson Charles   GLASSDOOR   GLG PARTNERS   GOLDMAN SACHS   Greenspan Alan   Greenspan Glenn   Grey Brad   Griffin Kathy   Griffin Ken   Grove Andy   HALSTON   HARBINGER CAPITAL   PARTNERS   Harrison Gilbert   Harrison Mya   HCR MANORCARE   HEWLETT-PACKARD   HILCO CONSUMER   CAPITAL   Hohman Robert   JEFFRIES & CO.   Jobs Steve   Johnson Magic   Johnson Robert   Jolie Angelina   Jordan Michael   JP MORGAN CHASE   Kaczynski Ted   Karan Donna   Kargman Jill   Karmazin Mel   Kashkari Neel   King Larry   Knowles Beyonce   KohlbergJerry   KopelmanArie   KopelsonAnne   KopelsonArnold   Korff Ira   Korff Kimberlee   Kurzman David   Lagrange Pierre   Lampert Eddie   Lansing Sherry   LEHMAN BROTHERS   LENDINGTREE   Levitt Arthur   Levy Leon   Liddy Ed   LINKEDIN   Little Edward   Loeb Allan   Lois George   LONG-TERM CAPITAL   MANAGEMENT   Lonski John   Lundgren Terry   MACYS   Madoff Bernie   Marcus Bernie   Marriott Bill   Maskin Eric   Mason Richard   MATTHEW WILLIAMSON   MAY DEPARTMENT   STORES   McCombs Red   McKinnon Mark   McLucas William   Meltzer Allan   MERRILL LYNCH   MGM   MICROSOFT   MIDWAY GAMES   Misner Jeff   Mitchell Andrea   Moglia Joe   Molinaro Sam   MOODYS INVESTORS   SERVICE   Moonves Leslie   Morgan Peter   MORGAN STANLEY   Moses Herb   MOTOROLA   Mozilo Angelo   Murdoch Rupert   Murphy Eddie   MYSPACE   Nader Ralph   Nardelli Bob   NATIONAL AMUSEMENTS   NEWS CORP.   Nicholas Pete   Nicklaus Tack   NICKLAUS DESIGN   NIKE   Norquist Grover   NRDC EQUITY PARTNERS   Obama Barack   ODYSSEY PARTNERS   Oman Brady   OPPENHEIMER & CO.   OReilly Bill   OReilly Tim   OVERTURE FILMS   Paese Michael   Palin Sarah   PALM   Pandit Vikram   PARAMOUNT PICTURES   Partnoy Frank   Pataki George   Paulson Henry   Paulson John   Preston Kelly   Purcell Philip   Pyle Jason   RBS GREENWICH CAPITAL   Reardon Roy   Redstone Brent   Redstone Eddie   Redstone Michael   Redstone Paula   Redstone Phyllis   Redstone Shari   Redstone Sumner   RELIANCE   RENAISSANCE TECHNOLOGIES   ROYAL DUTCH SHELL   Rubin Robert   SAC CAPITAL ADVISORS   SALTON   SAPPHIRE ENERGY   Schiff Stephen   Schrager Ian   Schumer Chuck   Schwartz Alan   Scott Lee   Shields Brooke   SHUTTERFLY   SIEMENS   Silverman Ben   Simons James   SIX APART   SOCIALIZR   SOLAZYME   Sorkin Aaron   Sorkin Andrew Ross   Soros George   Spielberg Steven   Spurlock Morgan   Stallone Sylvester   Stanley Stephen   Staubach Roger   Steel Robert   Steinberg Mark   Stern Andy   Stiglitz Joseph   ST. MARTINS PRESS   Stone Oliver   Sullivan Mark T.   Summers Lawrence   SUTTER HILL VENTURES   TACONIC CAPITAL PARTNERS   DESIGN TOMMY HILFIGER   Travolta John   Trump Ivanka   TSM CAPITAL   CENTURY FOX   AFRIKA   TYCO   UBS   UNITED ARTISTS   UNIVERSAL   VALENTINO FASHION   GROUP   VANTAGE   V AUSTRALIA   VENROCK ASSOCIATES   VIA COM   Volcker Paul   VONAGE   WACHOVIA   Wagner Paula   Wales Jimmy   Wallison Peter   WAL-MART   WarinJoseph   WARNER BROTHERS   WASHINGTON MUTUAL   Waters Maxine   Waxman Henry   Weinstein Bob   Weinstein Harvey   WEINSTEIN CO.   Weiser Stanley   Welch Jack   Welling Beau   Whitacre Ed   White Kevin   Whitehead John   Williams Brian   Wilson Victoria   WMS INDUSTRIES   Wolfson Jonathan    Copyright © 2009 StockRing.com. All rights reserved. Subscriber Agreement   Privacy Agreement   Stocks   MutualFunds Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither StockRing.com nor its partners shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the StockRing site, a user agrees not to redistribute the information found therein.

Buy from S&P 500:
Akamai - AKAM
Amazon.com - AMZN
Big Lots - BIG


Sell from S&P 500:
Alcoa - AA
Autodesk - ADSK
Aflac - AFL


Buy from S&P 400 MidCap:
Carmax - KMX
99c Stores - NDN
Netflix - NFLX


Sell from S&P 400 MidCap:
Timken - TKR
Trinity - TRN
Aflac - AFL


Buy from S&P 600 SmallCap:
Coinstar - CSTR
Holly - HOC
Maximus - MMS


Sell from S&P 600 SmallCap:
Barnes - B
Cascade - CAE
Brightpoint - CELL


Buy from Nasdaq 100:
Baidu.com - BIDU
Verisign - VRSN
Yahoo - YHOO


Sell from Nasdaq 100:
Adobe - ADBE
Amgen - AMGN
Costco - COST


Buy from Nasdaq Telecom:
Adtran - ADTN
CalAmp - CAMP
KongZhong - KONG


Sell from Nasdaq Telecom:
iBasis - IBAS
Interphase - INPH
RCN Corp - RCNI


Buy from Nasdaq Biotech:
Eurand - EURX
Illumina - ILMN
Trimeris - TRMS


Sell from Nasdaq Biotech:
Antigenics - AGEN
Celera - CRA
Incyte - INCY


Buy from Nasdaq Computer:
eLoyalty - ELOY
LogicVision - LGVN
Macrovision - MVSN


Sell from Nasdaq Computer:
Amtech - ASYS
Bsquare - BSQR
Corel - CREL


Buy from Nasdaq Finance:
Elbit - EMITF
Chardan - CACA
Tree.com - TREE


Sell from Nasdaq Finance:
BancFirst - BANF
FirstMerit - FMER
Advanta - ADVNA